The David Rubenstein Show
Dr. Selwyn Vickers
Jan 11, 2024
Dr. Selwyn Vickers, President & CEO of Memorial Sloan Kettering, discusses expanding cancer care and the role of environmental factors. He explores genetic factors in breast, ovarian, prostate, lung, brain, and pancreatic cancer, and the challenges of early detection. The potential impact of weight loss drug, Ozempic, on cancer is also discussed. Dr. Vickers shares his educational background, upbringing, experience with pancreatic cancer surgery, and qualities of a great surgeon.
24:09
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Cancer treatment has made significant progress over the past 50 years, with cure rates increasing from 30-40% to around 68-70%, showcasing the importance of research and advancements in the field.
- Early detection of cancer through screening methods like mammograms and colonoscopies greatly improves the chances of successful treatment, emphasizing the need for regular check-ups and awareness of symptoms.
Deep dives
Improvements in Cancer Treatment
Over the past 50 years since President Nixon declared war on cancer, there has been significant progress in treating cancer. The chances of a cure have increased from 30-40% to around 68-70% across the board. While there is no guaranteed way to prevent cancer, leading a healthy lifestyle, avoiding smoking, and limiting red meat consumption can potentially lower the risk. Early detection through screening, such as mammograms and colonoscopies, greatly improves the chances of successful treatment.
